StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was 23.4%, against 18.5% the year before. The highest annual figure on record is 23.4% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202523.4%+4.9
FY2024Dec 31, 202418.5%+0.6
FY2023Dec 31, 202317.9%+9.4
FY2022Dec 31, 20228.5%+5.6
FY2021Dec 31, 20212.8%−16.6
FY2020Dec 31, 202019.4%+7.4
FY2019Dec 31, 201912.0%−3.3
FY2018Dec 31, 201815.3%−1.0
FY2017Dec 31, 201716.4%−4.9
FY2016Dec 31, 201621.3%+4.7
FY2015Dec 31, 201516.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202620.6%+15.6
Q2 FY2025Jun 30, 202524.3%+10.6
Q2 FY2024Jun 30, 202421.2%+0.8
Q2 FY2023Jun 30, 202321.5%+13.0
Q2 FY2022Jun 30, 20225.0%−9.8
Q2 FY2021Jun 30, 202113.7%−5.0
Q2 FY2020Jun 30, 202020.5%–
Q2 FY2019Jun 30, 20198.5%–
Q2 FY2018Jun 30, 201814.8%–
Q2 FY2017Jun 30, 201718.7%–

More AstraZeneca figures

See a number that looks wrong?